$20.91
0.733.62%
At close: Aug 13, 5:00 PM EST
$20.80
0.623.07%
Pre-Market: 5:00 AM EST
Amphastar Pharmaceuticals Inc Earnings Estimates
AMPHNASDAQ
Amphastar Pharma Earnings Estimates, EPS & Revenue | NASDAQ:AMPH
Amphastar Pharma (AMPH) is scheduled to report Q3 earnings on November 5, 2026. Analysts estimate EPS of $0.82 and quarterly revenue of $197.42M.
In the most recent quarter (Q2), Amphastar Pharma reported EPS of $0.91, beating estimates of $0.62 by 0.47%. Revenue came in at $183.9M, exceeding the estimate of $180.36M by 0.02%.
Over the last 4 quarters, Amphastar Pharma has averaged an EPS surprise of 0.31% and a revenue surprise of 0.03%.
Earnings Date
Nov 5
EPS Estimate
$0.820
Quarterly Revenue Estimate
$197.42M
Annual Revenue
$730.02M
as of Jun 30
Amphastar Pharma Earnings History
Analyze the earnings history of Amphastar Pharma using advanced sorting and filters.
Amphastar Pharma (AMPH) Earnings Per Share
The chart below shows Amphastar Pharma's reported EPS compared to analyst estimates over recent quarters.
Amphastar Pharma (AMPH) Revenue
The chart below shows Amphastar Pharma's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Amphastar Pharma (NASDAQ:AMPH) reporting earnings?
Amphastar Pharma (AMPH) is scheduled to report earnings on November 5, 2026. The last reported earnings were for reported on August 6, 2026 for Q2.
What were the latest earnings per share (EPS) for Amphastar Pharma (NASDAQ:AMPH)?
The Actual EPS was $0.91, which beat the estimate of $0.62.
What were Amphastar Pharma’s (NASDAQ:AMPH) revenues?
The Actual Revenue was $183.9M, which beat the estimate of $180.36M.
